SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndine Biomed Regulatory News (OBI)

Share Price Information for Ondine Biomed (OBI)

Share Price is delayed by 15 minutes
Get Live Data
13.00    0.25 (1.96%)
Bid:
12.50
Ask:
13.50
Spread: 1.00 (8.00%)
Market Cap: £67.54m
OBI Live PriceLast checked at - London Stock Exchange

Intraday Ondine Biomed Share Chart

Date   Source Headline
31st Oct 20239:00 amRNSSteriwave use expanded following successful pilot
23rd Oct 20237:00 amRNS66.5% reduction in spine surgery infection rate
18th Oct 20237:00 amRNSSteriwave shown to reduce resistant bacteria
13th Oct 20237:00 amRNSSteriwave now in Canada's East Coast
10th Oct 20239:00 amRNSOndine to present poster at IP2023, Liverpool
9th Oct 20237:00 amRNSHospital to adopt Steriwave as standard-of-care
29th Sep 20239:00 amRNSBurnaby Hospital deploys Steriwave
25th Sep 20239:00 amRNSHalf-year Report
21st Sep 20237:00 amRNSMontreal Heart Institute pilots Steriwave
14th Sep 202312:00 pmRNSSteriwave proven effective against XDR bacteria
12th Sep 20239:00 amRNSSteriwave evaluation at major heart institute
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
29th Aug 20239:30 amRNSOndine to present new AMR research at ICPIC Geneva
21st Aug 20237:00 amRNSIssue of Equity and TVR
7th Aug 20239:00 amRNSOndine technology used in major Canadian hospital
1st Aug 20237:00 amRNSOndine commences first NHS Steriwave® pilot
17th Jul 202310:04 amRNSOndine receives impact award at IPA World Congress
7th Jul 20235:58 pmRNSCorporate Update
22nd Jun 20239:00 amRNSPhotodisinfection cuts COVID in meat processing
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSAnnual Report for the Year Ended 31 December 2022
10th May 20237:09 amRNSFull Year Results
3rd May 20233:30 pmRNSNotice of Results and Investor Presentation
3rd May 20238:02 amRNSNotice of AGM
3rd May 20237:56 amRNSIssue of Equity
20th Apr 202312:00 pmRNSOndine reports successful food pathogen study
18th Apr 202311:00 amRNSOndine Phase 2 results presented at ECCMID 2023
17th Apr 20237:00 amRNSProgress Update
5th Apr 20233:00 pmRNSOndine food-safe photodisinfection update
7th Mar 20237:00 amRNSLux Vitae advocates Steriwave for COVID prevention
3rd Mar 20237:00 amRNSOttawa hospital presents Steriwave study results
22nd Feb 20237:00 amRNSGrant of Share Options
31st Jan 202312:01 pmRNSOndine’s APDT reduces SARS-CoV-2 infectivity
17th Jan 202310:04 amRNSTR-1: Notification of major holdings
17th Jan 20239:30 amRNSNew photodisinfection study published
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Dec 202212:31 pmRNSAppointment of Nominated Adviser
12th Dec 20227:00 amRNSSteriwave receives regulatory approval in Mexico
5th Dec 20227:00 amRNSOndine receives funding for meat photodisinfection
2nd Dec 20226:25 pmRNSOndine receives funding for meat photodisinfection
2nd Dec 20227:00 amRNSOndine reports full results from Phase 2 trial
21st Nov 20227:00 amRNSOndine appoints Spanish distributer for Steriwave
7th Nov 20229:02 amRNSOndine cuts COVID-19 rate in food processing plant
4th Nov 20227:00 amRNSPDMR Dealing
31st Oct 202211:18 amRNSOndine CTO receives Lifetime Achievement Award
28th Oct 20227:00 amRNSPDMR Dealing
19th Oct 202212:07 pmRNSOndine presents new efficacy data against MRSA
19th Oct 202211:36 amRNSSteriwave™ cuts SSI risk by 47% at major hospital
11th Oct 20227:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.